Related Experiment Videos
Young onset Hemifacial Spasm in patients with Chiari type I malformation
Andre Carvalho Felício1, Clecio de Godeiro, Vanderci Borges
1Movement Disorders Unit, Department of Neurology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil. cf.andre@terra.com.br
Parkinsonism & Related Disorders
|May 25, 2007
Summary
Hemifacial spasm (HFS) linked to Chiari type I malformation (CIM) is uncommon. This study found HFS in 4.85% of CIM patients, noting early onset and potential BTX-A treatment effectiveness.
Area of Science:
- Neurology
- Neurosurgery
- Genetics
Background:
- Chiari type I malformation (CIM) is a rare cause of hemifacial spasm (HFS).
- Understanding the association between CIM and HFS is crucial for diagnosis and treatment.
- Peculiar phenotypic characteristics, such as a short neck, may be associated with CIM-related HFS.
Purpose of the Study:
- To evaluate the frequency of hemifacial spasm (HFS) in patients with Chiari type I malformation (CIM).
- To describe the clinical profile of HFS associated with CIM.
- To assess the efficacy of BTX-A injections as a treatment for HFS in CIM patients.
Main Methods:
- Retrospective evaluation of 103 subjects.
- Identification of patients with both CIM and HFS.
- Clinical data analysis and treatment outcome assessment for BTX-A injections.
Main Results:
- Hemifacial spasm (HFS) was found in 4.85% of the evaluated Chiari type I malformation (CIM) patients.
- HFS in CIM patients presented with young-onset facial spasms, differing from classical primary cases.
- Three patients treated with BTX-A injections showed favorable outcomes.
Conclusions:
- Hemifacial spasm (HFS) can be associated with Chiari type I malformation (CIM), particularly in young individuals with specific phenotypes like a short neck.
- BTX-A injections represent a viable alternative to posterior fossa decompression for HFS in selected CIM patients.
Related Concept Videos
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...